On CNBC's Fast Money, Guy Adami said that he would be a buyer of Facebook Inc FB and Goldman Sachs Group Inc GS going into fourth quarter. He expect them to post record earnings in October.
David Seaburg expects to see a recovery in iShares NASDAQ Biotechnology Index (ETF) IBB in the fourth quarter. He thinks that the high quality earners like Amgen, Inc. AMGN, Celgene Corporation CELG, Biogen Inc BIIB and Gilead Sciences, Inc. GILD are going to perform especially well.
Pete Najarian thinks that interest rates could go higher by the end of the year and that would be a positive for the banks. He likes JPMorgan Chase & Co. JPM in the space.
Brian Kelly likes the energy sector. He would be a buyer of Exxon Mobil Corporation XOM and he expects 15 percent return on that trade in the fourth quarter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.